Works by Munster, Pamela

Results: 53
    1
    2
    3
    4

    Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas.

    Published in:
    British Journal of Cancer, 2023, v. 129, n. 2, p. 291, doi. 10.1038/s41416-023-02298-8
    By:
    • Raj, Nitya;
    • Chan, Jennifer A.;
    • Wang, Stephanie J.;
    • Aggarwal, Rahul R.;
    • Calabrese, Susan;
    • DeMore, April;
    • Fong, Lawrence;
    • Grabowsky, Jennifer;
    • Hope, Thomas A.;
    • Kolli, Kanti Pallav;
    • Mulvey, Claire K.;
    • Munster, Pamela N.;
    • Perez, Kimberly;
    • Punn, Sippy;
    • Reidy-Lagunes, Diane;
    • Von Fedak, Sofia;
    • Zhang, Li;
    • Bergsland, Emily K.
    Publication type:
    Article
    5

    Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.

    Published in:
    British Journal of Cancer, 2018, v. 119, n. 9, p. 1086, doi. 10.1038/s41416-018-0235-2
    By:
    • Munster, Pamela;
    • Krop, Ian E.;
    • LoRusso, Patricia;
    • Ma, Cynthia;
    • Siegel, Barry A.;
    • Shields, Anthony F.;
    • Molnár, István;
    • Wickham, Thomas J.;
    • Reynolds, Joseph;
    • Campbell, Karen;
    • Hendriks, Bart S.;
    • Adiwijaya, Bambang S.;
    • Geretti, Elena;
    • Moyo, Victor;
    • Miller, Kathy D.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.

    Published in:
    Cancer Management & Research, 2019, v. 11, p. 10463, doi. 10.2147/CMAR.S208720
    By:
    • Munster, Pamela;
    • Mita, Monica;
    • Mahipal, Amit;
    • Nemunaitis, John;
    • Massard, Christophe;
    • Mikkelsen, Tom;
    • Cruz, Cristina;
    • Paz-Ares, Luis;
    • Hidalgo, Manuel;
    • Rathkopf, Dana;
    • Jr, George Blumenschein;
    • Smith, David C;
    • Eichhorst, Barbara;
    • Cloughesy, Tim;
    • Filvaroff, Ellen H;
    • Li, Shaoyi;
    • Raymon, Heather;
    • Haan, Hans de;
    • Hege, Kristen;
    • Bendell, Johanna C
    Publication type:
    Article
    12
    13
    14
    15

    Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.

    Published in:
    2021
    By:
    • Martin, Thomas G.;
    • Shah, Nina;
    • Richter, Joshua;
    • Vesole, David H.;
    • Wong, Sandy W.;
    • Huang, Chiung‐Yu;
    • Madduri, Deepu;
    • Jagannath, Sundar;
    • Siegel, David S.;
    • Biran, Noa;
    • Wolf, Jeffrey L.;
    • Parekh, Samir;
    • Cho, Hearn J.;
    • Munster, Pamela;
    • Richard, Shambavi;
    • Ziti‐Ljajic, Samira;
    • Chari, Ajai;
    • Huang, Chiung-Yu;
    • Ziti-Ljajic, Samira
    Publication type:
    journal article
    16

    A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.

    Published in:
    2015
    By:
    • Bendell, Johanna C.;
    • Kelley, Robin K.;
    • Shih, Kent C.;
    • Grabowsky, Jennifer A.;
    • Bergsland, Emily;
    • Jones, Suzanne;
    • Martin, Thomas;
    • Infante, Jeffrey R.;
    • Mischel, Paul S.;
    • Matsutani, Tomoo;
    • Xu, Shuichan;
    • Wong, Lilly;
    • Liu, Yong;
    • Wu, Xiaoling;
    • Mortensen, Deborah S.;
    • Chopra, Rajesh;
    • Hege, Kristen;
    • Munster, Pamela N.
    Publication type:
    journal article
    17

    Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors.

    Published in:
    2016
    By:
    • Sarantopoulos, John;
    • Goel, Sanjay;
    • Chung, Vincent;
    • Munster, Pamela;
    • Pant, Shubham;
    • Patel, Manish;
    • Infante, Jeffrey;
    • Tawbi, Hussein;
    • Becerra, Carlos;
    • Bruce, Justine;
    • Kabbinavar, Fairooz;
    • Lockhart, A.;
    • Tan, Eugene;
    • Yang, Shu;
    • Carlson, Gary;
    • Scott, Jeffrey;
    • Sharma, Sunil;
    • Patel, Manish R;
    • Lockhart, A Craig;
    • Scott, Jeffrey W
    Publication type:
    journal article
    18
    19

    Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 3, p. 467, doi. 10.1007/s00280-013-2372-x
    By:
    • Mahadevan, Daruka;
    • Sutton, Gregory;
    • Arteta-Bulos, Rafael;
    • Bowden, Chris;
    • Miller, Paul;
    • Swart, Rachel;
    • Walker, Mark;
    • Haluska, Paul;
    • Munster, Pamela;
    • Marshall, John;
    • Hamid, Omid;
    • Kurzrock, Razelle
    Publication type:
    Article
    20

    A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

    Published in:
    Oncology, 2019, v. 97, n. 2, p. 102, doi. 10.1159/000500571
    By:
    • Hong, David;
    • Rasco, Drew;
    • Veeder, Michael;
    • Luke, Jason J.;
    • Chandler, Jason;
    • Balmanoukian, Ani;
    • George, Thomas J.;
    • Munster, Pamela;
    • Berlin, Jordan D.;
    • Gutierrez, Martin;
    • Mita, Alain;
    • Wakelee, Heather;
    • Samakoglu, Selda;
    • Guan, Shanhong;
    • Dimery, Isaiah;
    • Graef, Thorsten;
    • Borazanci, Erkut
    Publication type:
    Article
    21
    22
    23

    Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate.

    Published in:
    Science Translational Medicine, 2013, v. 5, n. 198, p. 1, doi. 10.1126/scitranslmed.3006070
    By:
    • Nelson, Sarah J.;
    • Kurhanewicz, John;
    • Vigneron, Daniel B.;
    • Larson, Peder E. Z.;
    • Harzstark, Andrea L.;
    • Ferrone, Marcus;
    • van Criekinge, Mark;
    • Chang, Jose W.;
    • Bok, Robert;
    • Park, Ilwoo;
    • Reed, Galen;
    • Carvajal, Lucas;
    • Small, Eric J.;
    • Munster, Pamela;
    • Weinberg, Vivian K.;
    • Ardenkjaer-Larsen, Jan Henrik;
    • Chen, Albert P.;
    • Hurd, Ralph E.;
    • Odegardstuen, Liv-Ingrid;
    • Robb, Fraser J.
    Publication type:
    Article
    24
    25
    26
    27
    28

    Specialized computational methods for denoising, B<sub>1</sub> correction, and kinetic modeling in hyperpolarized <sup>13</sup>C MR EPSI studies of liver tumors.

    Published in:
    Magnetic Resonance in Medicine, 2021, v. 86, n. 5, p. 2402, doi. 10.1002/mrm.28901
    By:
    • Lee, Philip M.;
    • Chen, Hsin‐Yu;
    • Gordon, Jeremy W.;
    • Zhu, Zihan;
    • Larson, Peder E.Z.;
    • Dwork, Nicholas;
    • Van Criekinge, Mark;
    • Carvajal, Lucas;
    • Ohliger, Michael A.;
    • Wang, Zhen J.;
    • Xu, Duan;
    • Kurhanewicz, John;
    • Bok, Robert A.;
    • Aggarwal, Rahul;
    • Munster, Pamela N.;
    • Vigneron, Daniel B.
    Publication type:
    Article
    29

    Technique development of 3D dynamic CS‐EPSI for hyperpolarized <sup>13</sup>C pyruvate MR molecular imaging of human prostate cancer.

    Published in:
    Magnetic Resonance in Medicine, 2018, v. 80, n. 5, p. 2062, doi. 10.1002/mrm.27179
    By:
    • Chen, Hsin‐Yu;
    • Larson, Peder E. Z.;
    • Gordon, Jeremy W.;
    • Bok, Robert A.;
    • Ferrone, Marcus;
    • van Criekinge, Mark;
    • Carvajal, Lucas;
    • Cao, Peng;
    • Pauly, John M.;
    • Kerr, Adam B.;
    • Park, Ilwoo;
    • Slater, James B.;
    • Nelson, Sarah J.;
    • Munster, Pamela N.;
    • Aggarwal, Rahul;
    • Kurhanewicz, John;
    • Vigneron, Daniel B.
    Publication type:
    Article
    30
    31

    Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16344-z
    By:
    • Färkkilä, Anniina;
    • Gulhan, Doga C.;
    • Casado, Julia;
    • Jacobson, Connor A.;
    • Huy Nguyen;
    • Kochupurakkal, Bose;
    • Maliga, Zoltan;
    • Yapp, Clarence;
    • Yu-An Chen;
    • Schapiro, Denis;
    • Yinghui Zhou;
    • Graham, Julie R.;
    • Dezube, Bruce J.;
    • Munster, Pamela;
    • Santagata, Sandro;
    • Garcia, Elizabeth;
    • Rodig, Scott;
    • Lako, Ana;
    • Chowdhury, Dipanjan;
    • Shapiro, Geoffrey I.
    Publication type:
    Article
    32

    Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15315-8
    By:
    • Färkkilä, Anniina;
    • Gulhan, Doga C.;
    • Casado, Julia;
    • Jacobson, Connor A.;
    • Nguyen, Huy;
    • Kochupurakkal, Bose;
    • Maliga, Zoltan;
    • Yapp, Clarence;
    • Chen, Yu-An;
    • Schapiro, Denis;
    • Zhou, Yinghui;
    • Graham, Julie R.;
    • Dezube, Bruce J.;
    • Munster, Pamela;
    • Santagata, Sandro;
    • Garcia, Elizabeth;
    • Rodig, Scott;
    • Lako, Ana;
    • Chowdhury, Dipanjan;
    • Shapiro, Geoffrey I.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.

    Published in:
    Breast Cancer Research & Treatment, 2016, v. 155, n. 3, p. 521, doi. 10.1007/s10549-016-3701-7
    By:
    • Chien, Amy;
    • Cockerill, Alyson;
    • Fancourt, Craig;
    • Schmidt, Emmett;
    • Moasser, Mark;
    • Rugo, Hope;
    • Melisko, Michelle;
    • Ko, Andrew;
    • Kelley, R.;
    • Korn, W.;
    • Esserman, Laura;
    • Veer, Laura;
    • Yau, Christina;
    • Wolf, Denise;
    • Munster, Pamela
    Publication type:
    Article
    44
    45
    46

    A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.

    Published in:
    Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 1057, doi. 10.1007/s10549-012-2003-y
    By:
    • Lin, Nancy;
    • Winer, Eric;
    • Wheatley, Duncan;
    • Carey, Lisa;
    • Houston, Stephen;
    • Mendelson, David;
    • Munster, Pamela;
    • Frakes, Laurie;
    • Kelly, Steve;
    • Garcia, Agustin;
    • Cleator, Susan;
    • Uttenreuther-Fischer, Martina;
    • Jones, Hilary;
    • Wind, Sven;
    • Vinisko, Richard;
    • Hickish, Tamas
    Publication type:
    Article
    47
    48
    49
    50